Human Papillomavirus Associated With Higher Risk of New HIV Infection
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Human Papillomavirus Associated With Higher Risk of New HIV Infection

SAN FRANCISCO -- May 1, 2009 -- Infection with anal human papillomavirus (HPV) is associated with a higher risk of new HIV infection in previously HIV-negative men who have sex with men (MSM), according to a study released early online and appearing in an upcoming print issue of the journal AIDS.

"We looked at HIV-negative men who have sex with men who were at high risk for HIV infection and who had multiple risk factors," said lead author Peter V. Chin-Hong, MD, University of California at San Francisco (UCSF), San Francisco, California.

"Our results showed a strong independent association for increased risk of HIV acquisition among those men who were already infected with anal HPV."

The 1,400 study participants were part of the EXPLORE trial, a large clinical study to test the efficacy of a behavioural intervention for HIV-negative MSM. Risk factors were calculated from those men who became HIV-infected over the course of the trial and infections were identified by blood tests.

"We think that HPV enhances susceptibility to HIV infection through 2 mechanisms. Anatomically, the virus causes anal lesions," said Dr. Chin-Hong. "These lesions bring blood vessels closer to the surface and also the lesions' skin layer is thinner and more easily shredded, which frequently causes bleeding. These disruptions of the mucosal barrier could allow easier entry for HIV."

In addition, HPV activates the immune system. The inflammatory cells recruited to the HPV lesions -- dendritic cells, macrophages and CD4 T cells -- are the immune cells most susceptible to HIV infection.

HPV vaccine has been found effective in preventing acquisition of the virus by women. Clinical trials testing the effectiveness of the vaccine among MSM are currently under way.

"To date, the focus of attention on HPV has been almost exclusively on its key role in causing squamous cell cancer," said senior investigator Joel Palefsky, MD, Anal Neoplasia Clinic at UCSF.

"This study points to another important means by which HPV infection may be associated with morbidity and mortality -- through potentiation of HIV infection. A direct role for HPV in this process will need to be confirmed in additional studies, and additional studies will be needed to understand the mechanisms by which HPV may do this."

"But it is encouraging to note that to the degree that HPV truly plays a role in increasing the risk of acquiring HPV infection, primary prevention of HPV infection through HPV vaccination may potentially reduce that risk," he added.

SOURCE: University of California at San Francisco

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities